HUM

Business Context and Reporting Period

Company: Humana Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: June 30, 1996
Business Overview: Humana provides managed health care products through HMOs and PPOs, serving commercial groups, Medicare risk, and Medicare supplement markets. The company recently acquired EMPHESYS Financial Group, Inc. and entered a new contract with the Department of Defense (CHAMPUS).

Key Financial Metrics

Key Ratios (Q2 1996, excluding special charges):

• Medical Loss Ratio: 82.9% (vs 82.1% in Q2 1995)
• Administrative Cost Ratio: 15.2% (vs 13.4% in Q2 1995)

Material Changes vs. Prior Period

Revenue Growth: Premium revenues increased 50.7% in Q2 and 51.4% for the six months ended June 30, 1996, compared to 1995. This growth is primarily attributed to the acquisition of EMPHESYS Financial Group, Inc. in late 1995.

Profitability Decline: The company reported a net loss of $95 million for Q2 1996 and $42 million for the six-month period, compared to net income of $45 million and $98 million in the prior year periods. This reversal is driven by special charges of $200 million pretax ($130 million after-tax) recognized in Q2 1996.

Special Charges Breakdown:

• $105 million: Provision for expected future losses on insurance contracts (primarily Washington, D.C. health plan).
• $70 million: Restructuring costs for the Washington, D.C. plan and closing/discontinuing products in 16 market areas.
• $25 million: Asset write-offs, litigation settlements, and other costs.

Membership Trends: Commercial membership decreased slightly in Q2 1996 due to strategic pricing and market exits, while Medicare risk membership increased by 10,600 members.

Guidance, Outlook, and Risks

Management Commentary: Excluding special charges, the company reported adjusted net income of $35 million ($0.22 per share) for Q2 1996. Management anticipates the medical loss ratio will not improve for the remainder of 1996 due to competitive pricing and rising medical costs. Administrative cost ratios are expected to remain flat or decline slightly.

Outlook:

• CHAMPUS Contract: A new five-year potential contract with the Department of Defense began July 1, 1996, expected to generate approximately $340 million in additional premium revenue for the remainder of 1996.
• Medicare Rates: The projected national average rate increase for 1997 is 7.2%, though final rates are pending announcement in September 1996.
• Capital Spending: Planned capital expenditures for 1996 are estimated at $65 million to $70 million.

Risks and Contingencies:

• Legislative Risk: Potential changes to Medicare reimbursement rates or benefits could materially adversely affect profitability.
• CHAMPUS Uncertainty: As a new program, the success of the Department of Defense contract is uncertain.
• Litigation: A class action settlement (Bruns case) is pending final court approval, with an accrual of approximately $7.5 million included in special charges.

Investor Verification Checklist

• Special Charges Impact: Verify the sustainability of operations by analyzing financial performance excluding the $200 million one-time charges.
• Medical Loss Ratio Trend: Monitor the 82.9% loss ratio to ensure it does not widen further given the competitive pricing environment.
• CHAMPUS Execution: Assess the company's ability to successfully integrate and manage the new Department of Defense contract starting July 1996.
• Medicare Rate Finalization: Confirm the final 1997 Medicare rate increase announced in September 1996 to validate revenue projections.
• Liquidity Position: Review the utilization of the $600 million revolving credit facility and commercial paper program to ensure sufficient working capital.